Sort
64,565 grants matching “drug discovery”
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
$672,668Henry L Wong · University Of Minnesota · R33 · FY2023 · HD
Discovering Affective Drug Combinations for Treating Covid-19
$672,569Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Hemopexin as an Early Biomarker of Anthracycline Cardiac Toxicity
$672,532Aarti Asnani · Beth Israel Deaconess Medical Center · R01 · FY2022 · HL
Development of a Miniature Mass Spectromtry System for Point-of-Care Applications
$672,527Zheng Ouyang · Purspec Technologies, Inc. · R44 · FY2017 · GM
Lead Optimization of Lapatinib Analogs for Human African Trypanosomiasis
$672,488Kojo Mensa-Wilmot · University Of Georgia · R56 · FY2014 · AI
RNA METABOLISM IN TRYPANOSOMES
$672,251Elisabetta Ullu · Yale University · R37 · FY2013 · AI
PD-1/PD-L1 modulation in cancer therapy
$672,206Drew M. Pardoll · Johns Hopkins University · R01 · FY2020 · CA
Use of silver nanostructures on microtransponders in ultra-sensitive assay
$672,201Wlodek Mandecki · Pharmaseq, Inc. · R44 · FY2010 · CA
Structural, mechanistic, & evolutionary characterization of tetracycline destructases
$672,172Gautam Dantas · Washington University · U01 · FY2025 · AI
Novel Therapeutics for Cardiovascular Disease
$672,130Sasantha Jeson Sangaralingham · Mayo Clinic Rochester · R01 · FY2024 · HL
T7 RNA polymerase engineering and RNA amplification
$672,066Andrew D Ellington · Accacia International, Inc. · R42 · FY2007 · GM
Targeting RAGE/DIAPH1: Novel Therapeutic Strategy for Diabetic Complications
$672,000Ann Marie Schmidt · New York University School Of Medicine · R01 · FY2020 · DK
The Impact of Pharmaceutical Industry Messaging on the Opioid Crisis among U.S. Military Veterans
$671,958Christopher Keith Haddock · Ndri-Usa, Inc. · R01 · FY2023 · DA
Anti-folate chemotype protein degraders
$671,951James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
$671,935Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2022 · MD
Mechanisms of FGF Receptor Regulation and Signaling
$671,931Moosa Mohammadi · New York University School Of Medicine · R01 · FY2016 · DE
HTS Assays for Modulators of GPCR Signaling
$671,897Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2009 · NS
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$671,855Paul S Mischel · Stanford University · R01 · FY2022 · CA
Structural Studies and Drug Discovery to Interrogate the Function of Neuronal SLC4 Transporters
$671,775Daniel Wacker · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · NS
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
$671,753Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2019 · AG
Screening for Molecules that Promote Photoreceptor Synaptogenesis
$671,689Donald J Zack · Johns Hopkins University · U01 · FY2018 · EY
Discovery of First-in-class WDR5 PROTACs as a Novel Therapeutic Strategy for MLL-rearranged Leukemias
$671,604Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
A network approach to interrogate cellular plasticity and drug resistance in cancer
$671,594Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2024 · CA
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$671,571Tracy M Handel · University Of California, San Diego · R01 · FY2023 · AI
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
$671,549Jin Wang · Baylor College Of Medicine · R01 · FY2020 · CA